Latest Market News

Aspermont Limited has appointed John Stark and David Straface as interim directors, reinforcing its board with seasoned insiders during a pivotal growth phase focused on data and intelligence services for global resource sectors.

ReNerve Limited has raised $3.2 million through a two-tranche share placement to accelerate its sales and marketing efforts in the US and support upcoming product launches, including a new nerve conduit range.

LaserBond’s 2025 AGM reveals a pivotal CEO transition alongside a strong financial rebound driven by strategic investments and technology licensing deals.

Cann Group Limited has successfully raised an additional $2.5 million through a Share Purchase Plan and shortfall placement, complementing a prior $6.5 million institutional placement. These funds will primarily support debt repayment and strengthen the company’s financial position.

Strata Minerals is set to begin its first drilling program at the Zelica Gold Project in Western Australia, targeting high-grade shallow gold mineralisation along a 1km strike zone. The company aims to validate historical results and explore near-term mining potential on granted licences.

Growthpoint Properties Australia reported a robust FY25 with funds from operations exceeding guidance, expanded funds management assets, and achieved its Net Zero emissions target ahead of schedule. The company reaffirmed positive FY26 outlook amid leadership changes and ongoing sustainability commitments.

HeraMED has achieved a significant regulatory milestone with the Therapeutic Goods Administration upgrading its HeraBEAT fetal heart rate monitor to Class IIb, making it the only remote home-use device approved in Australia. This positions the company for a potentially lucrative expansion in the Australian maternity care market.

Cazaly Resources has raised $3.5 million through a strongly supported placement to accelerate reverse circulation drilling at its Goongarrie Gold Project in Western Australia. The capital injection positions the company to expand exploration efforts and advance key targets in a promising gold region.

Accelerate Resources has reported exceptional high-grade manganese results from newly acquired exploration licenses at its Woodie Woodie North Project, revealing new mineralised corridors and expanding its resource potential.

AustChina Holdings has raised $1.5 million through a private placement with Bluestone Energy, aiming to accelerate acquisitions and exploration across its energy and mineral projects.

Island Pharmaceuticals has engaged a top Washington DC government affairs firm to accelerate its US biodefence strategy, focusing on its antiviral drug Galidesivir amid promising FDA regulatory signals.

DroneShield Limited has clarified the recent exercise and sale of shares by its directors following performance option vesting, alongside addressing an erroneous contract announcement that was later withdrawn. The company also outlined steps to enhance compliance with ASX continuous disclosure and trading policies.